Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000098

Director sold 92,500 shares at $20.50 ($1,896,250)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Krognes Steve E. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-04-01 Sale : show line 1 in the form 10b5-1 −92,500 $20.50 $1,896,250 47,341 D
Open-market sales · 92,500 sh · avg $20.50 · $1,896,250
Loading xslF345X05/wk-form4_1712095651.xml…